Seaport Therapeutics

Seaport Therapeutics is a biotechnology company based in Boston developing precision therapeutics for oncology and immune‑mediated diseases. The firm leverages a proprietary discovery platform to identify and engineer targeted biologics and small molecules that modulate disease‑relevant pathways. Seaport advances programs from discovery through early clinical development and collaborates with academic and industry partners to accelerate translation. Investors and collaborators are drawn to its scientific focus on creating safer, more effective treatments for patients.